Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 1.6200
- 0.00000.00%
Close Feb 14 16:00 ET
- 1.6200
- 0.00000.00%
Post 18:17 ET
2.59MMarket Cap-0.22P/E (TTM)
1.6200High1.5932Low5.66KVolume1.6200Open1.6200Pre Close9.13KTurnover0.40%Turnover RatioLossP/E (Static)1.60MShares26.000052wk High0.95P/B2.32MFloat Cap1.500052wk Low--Dividend TTM1.43MShs Float36000.0000Historical High--Div YieldTTM1.65%Amplitude1.5000Historical Low1.6120Avg Price1Lot Size
Alaunos Therapeutics News
Alaunos Therapeutics | SCHEDULE 13G/A: Others
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vieser Jaime
Alaunos Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(6.3%),MSD Credit Opportunity Master Fund, L.P.(6.3%), etc.
Alaunos Therapeutics | 10-Q: Q3 2024 Earnings Report
Alaunos Therapeutics | 8-K: Current report
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Groenewald Ferdinand
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lackey Melinda
Alaunos Therapeutics | 10-Q: Q2 2024 Earnings Report
Alaunos Therapeutics | 8-K/A: Current report (Amendment)
Alaunos Therapeutics | 8-K/A: Current report (Amendment)
Alaunos Therapeutics | 8-K: Current report
Alaunos Therapeutics | 8-K: Current report
Alaunos Therapeutics | 8-K: Current report
Alaunos Therapeutics | 8-K: Current report
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weis Holger
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vieser Jaime
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Postma Robert W
Alaunos Therapeutics | 10-Q: Q1 2024 Earnings Report
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.